Irreversible Inhibition of Mitochondrial Complex I by 1‐Methyl‐4‐Phenylpyridinium: Evidence for Free Radical Involvement
Data up to Jan 2025
Total Citations Per Year
Abstract
References (29)
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
1951 • 319,299 citations
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
1983 • 4,822 citations
The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen
1973 • 2,608 citations
Mitochondrial Complex I Deficiency in Parkinson's Disease
1990 • 2,147 citations
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
1989 • 1,717 citations
Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria
1980 • 1,609 citations
Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease
1989 • 1,369 citations
Chronic parkinsonism secondary to intravenous injection of meperidine analogues
1979 • 1,356 citations
Anatomic and Disease Specificity of NADH CoQ1 Reductase (Complex I) Deficiency in Parkinson's Disease
1990 • 676 citations
A Selective Increase in Particulate Superoxide Dismutase Activity in Parkinsonian Substantia Nigra
1989 • 445 citations
A large kindred with autosomal dominant Parkinson's disease
1990 • 411 citations
Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, by mitochondria.
1986 • 404 citations
1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles
1990 • 323 citations
[40] Preparations of succinate—cytochrome c reductase and the cytochrome b-c1 particle, and reconstitution of succinate-cytochrome c reductase
1967 • 223 citations
Interaction of 1‐Methyl‐4‐Phenylpyridinium Ion (MPP+) and Its Analogs with the Rotenone/Piericidin Binding Site of NADH Dehydrogenase
1991 • 214 citations
MPTP: A neurotoxin producing a parkinsonian syndrome
1987 • 146 citations
[43] Preparation and properties of DPNH-coenzyme Q reductase (complex I of the respiratory chain)
1967 • 135 citations
Twin studies and the genetics of Parkinson's disease—a reappraisal
1990 • 129 citations
The role of iron chelates in hydroxyl radical production by rat liver microsomes, NADPH-cytochrome P-450 reductase and xanthine oxidase
1984 • 127 citations
The inhibition site of MPP+, the neurotoxic bioactivation product of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine is near the Q-binding site of NADH dehydrogenase
1987 • 107 citations
Mitochondria. A practical approach
1988 • 96 citations
The specific vulnerability of the substantia nigra to MPTP is related to the presence of transition metals
1985 • 96 citations
Formation of superoxide and hydroxyl radicals from 1-methyl-4-phenylpyridinium ion(MPP+): Reductive activation by NADPH cytochrome P-450 reductase
1986 • 89 citations
1-methyl-4-phenylpyridine (MPP+) induces oxidative stress in the rodent
1986 • 88 citations
Model study on the bioreduction of paraquat, MPP+, and analogs. Evidence against a “redox cycling” mechanism in MPTP neurotoxicity
1987 • 74 citations
Ascorbic acid reduces the dopamine depletion induced by MPTP
1985 • 64 citations
Protection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity by the antioxidant ascorbic acid
1985 • 61 citations
Chemically induced Parkinson's disease: Intermediates in the oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to the 1-methyl-4-phenyl-pyridinium ion
1987 • 36 citations
Chemically induced parkinson's disease II: Intermediates in the oxidation and reduction reactions of the 1-methyl-4-phenyl-2,3-dihydropyridinium ion and its deprotonated form
1989 • 16 citations